KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbbVie (ABBV) Long-Term Debt Repayments (2016 - 2025)

AbbVie (ABBV) has disclosed Long-Term Debt Repayments for 11 consecutive years, with $8.0 million as the latest value for Q4 2025.

  • Quarterly Long-Term Debt Repayments fell 99.86% to $8.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $6.8 billion through Dec 2025, down 29.29% year-over-year, with the annual reading at $6.8 billion for FY2025, 29.29% down from the prior year.
  • Long-Term Debt Repayments for Q4 2025 was $8.0 million at AbbVie, down from $9.0 million in the prior quarter.
  • The five-year high for Long-Term Debt Repayments was $6.9 billion in Q4 2022, with the low at $2.0 million in Q2 2022.
  • Average Long-Term Debt Repayments over 5 years is $2.3 billion, with a median of $2.2 billion recorded in 2021.
  • The sharpest move saw Long-Term Debt Repayments plummeted 99.94% in 2022, then skyrocketed 50000.0% in 2023.
  • Over 5 years, Long-Term Debt Repayments stood at $3.8 billion in 2021, then soared by 82.6% to $6.9 billion in 2022, then plummeted by 73.81% to $1.8 billion in 2023, then soared by 221.18% to $5.8 billion in 2024, then plummeted by 99.86% to $8.0 million in 2025.
  • According to Business Quant data, Long-Term Debt Repayments over the past three periods came in at $8.0 million, $9.0 million, and $3.8 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.